May 1, 2026 · Mayo Clinic proceedings · DOI: 10.1016/j.mayocp.2026.02.002

Heart Failure Phenotypes and the Prognostic Utility of NT-proBNP in Patients With Chronic Kidney Disease: A Propensity-Score Matched Cohort Study

Listen to this summary

The authors aimed to assess the prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in predicting outcomes across different heart failure phenotypes in patients with chronic kidney disease (CKD). The study found that patients with heart failure with reduced ejection fraction (HFrEF) had higher NT-proBNP levels and an increased risk of all-cause mortality and major adverse cardiac events compared to those with heart failure with preserved ejection fraction (HFpEF), while NT-proBNP's predictive value for renal outcomes was limited.

Chien-Chou Chen, Cai-Mei Zheng, Chih-Chin Kao, Yenn-Jiang Lin, Shih-Hua Lin, Mai-Szu Wu, Yen-Chung Lin

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play